P A Sheiner1, L K Schluger, S Emre
1Department of Surgery, Mount Sinai Medical Center of the City University of New York, New York, USA.
Liver retransplantation for recurrent hepatitis C virus (HCV) is a viable option, with 8 of 14 patients surviving long-term. Early retransplantation before complications improves outcomes for patients with progressive liver disease.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: